ADA Scientific Sessions 2026 Abstract

SPID-Engineered Long-Acting GIPR Antagonist Antibody for Weight Maintenance and Glycemic Recovery

By Jihye Jo, Hyoung-Tae An, Changju Chun, Hongwon Lee

Experiments in animalsInterventions

The paper

Jihye Jo, Hyoung-Tae An, Changju Chun, Hongwon Lee

Seoul

ADA Scientific Sessions 2026 Abstract, 8 Jun 2026

Presented at ADA Scientific Sessions 2026, oral 1320-OR

doi.org/10.2337/db26-1320-or

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety